Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Chorev

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Oncotarget|September 1, 2012
Tumor suppression by small molecule inhibitors of translation initiationLimo Chen, Bertal H Aktas, Yibo Wang, et al.
Journal of the American Chemical Society|March 29, 2007
Ultrahigh-resolution (1)H-(13)C HSQC spectra of metabolite mixtures using nonlinear sampling and forward maximum entropy reconstructionSven G Hyberts, Gregory J Heffron, Nestor G Tarragona, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011
Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidationCharles A Hoeffer, Kiriana K Cowansage, Elizabeth C Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4GEvangelos Papadopoulos, Simon Jenni, Eihab Kabha, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Journal of Medicinal Chemistry|November 15, 2002
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's diseaseJeffrey Sterling, Yaacov Herzig, Tamar Goren, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Oncotarget|September 1, 2012
Tumor suppression by small molecule inhibitors of translation initiationLimo Chen, Bertal H Aktas, Yibo Wang, et al.
Journal of the American Chemical Society|March 29, 2007
Ultrahigh-resolution (1)H-(13)C HSQC spectra of metabolite mixtures using nonlinear sampling and forward maximum entropy reconstructionSven G Hyberts, Gregory J Heffron, Nestor G Tarragona, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011
Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidationCharles A Hoeffer, Kiriana K Cowansage, Elizabeth C Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4GEvangelos Papadopoulos, Simon Jenni, Eihab Kabha, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Journal of Medicinal Chemistry|November 15, 2002
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's diseaseJeffrey Sterling, Yaacov Herzig, Tamar Goren, et al.
Pageof 6